Inactive
Notice ID:36C26123Q1196
Department of Veterans Affairs (VA) Network Contracting Office (NCO 21) intends to award a sole source, firm fixed price contract to Trillamed, LLC for 6 doses of F18 Fluciclovine (Axumin). Fluciclovi...
Department of Veterans Affairs (VA) Network Contracting Office (NCO 21) intends to award a sole source, firm fixed price contract to Trillamed, LLC for 6 doses of F18 Fluciclovine (Axumin). Fluciclovine, also known as anti-1-amino-3-18F-fluorocyclobutane-1- carboxylic acid, or as Axumin to be delivered on an as needed basis. The procurement is on behalf of the Department of Veterans Affairs, Veterans Health Administration, Regional Procurement Office West (RPOW), Network Contracting Office (NCO) 21, on behalf of Southern Nevada Healthcare System LAS VEGAS. The specific items required are as follows: ITEM NUMBER DESCRIPTION OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT 0001 6.00 EA FLUCICLOVINE (AXUMIN F18) INJECTION 6QTY X $5,179.00 = $31,074.00 0002 6.00 EA PETNET DELIVERY/LOGISTICS 6QTY X $505.00 = $3,030.00 VA s Gray Market Items terms and conditions apply pursuant to VAAR 852.212-71 Gray Market Items and VAAR 852.212-72 Gray Market and Counterfeit Items. As a result, vendor shall be an OEM, authorized dealer, authorized distributor or authorized reseller for the items identified to be eligible for participation with this acquisition. Vendor must be able to provide the documentation that demonstrates such aforementioned authority. The solicitation for this action will be posted to beta.sam.gov and all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. After consideration, the Government will determine whether to proceed with the sole source acquisition. Please keep in mind that patient care and choice in the decision is the highest priority to the VA. The solicitation will be posted on or about August 29, 2023. Please respond to mariah.montalvo@va.gov no later than Monday, August 29, 2023 at 14:00pm Pacific time. With your response, please provide evidence showing compliance with the aforementioned Gray Market clauses. Failure to provide the required information may result in a determination that your company is not a viable source. (End of Notice)
